Dapiglutide
A Trial Comparing Pharmacokinetics, Safety and Tolerability of Two Subcutaneous Concentrations of Dapiglutide
Zealand Pharma · Phase 1 · Completed · Enrollment 30
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Dapiglutide 10 mg/mL | n/r | n/r | n/r | n/r |
| Dapiglutide 25 mg/mL | n/r | n/r | n/r | n/r |
Not shown
- Dapiglutide 10 mg/mL: endpoint not reported
- Dapiglutide 25 mg/mL: endpoint not reported